| Completed |
: A Phase 2 Study of Clofarabine, Idarubicin, Cytarabine, Vincristine, and Corticosteroids - Mixed Phenotype Acute Leukemia (MPAL)
: Leukemia
: 2014-05-08
:
|
| Terminated |
: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
: - Mixed Lineage Acute Leukemia
- Acute Myeloid Leukemia
: 2015-04-14
: - Drug: Bortezomib Bortezomib wi
|
| Completed |
: Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia
: - Acute Leukemias of Ambiguous Lineage
- Philadelphia Chromosome Ne
: 2010-05-26
: - Drug: entinostat Given PO
|
| Recruiting |
: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
: - Acute Biphenotypic Leukemia
- Acute Myeloid Leukemia
: 2016-03-14
: - Drug: Cladribine Given IV
|
| Active, not recruiting |
: Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
: - Acute Biphenotypic Leukemia
- Acute Myeloid Leukemia
: 2013-03-01
: - Other: Laboratory Biomarker Analysis
|
| Completed |
: Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
: - Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
-
- Drug: Selinexor Given orally o
|
| Recruiting |
: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
: - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Acut
: 2014-08-18
: - Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
|
| Active, not recruiting |
: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children
: - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Acut
: 2013-05-15
: - Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
|
| Recruiting |
: Decitabine, Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
: - de Novo Myelodysplastic Syndrome
- Mixed Phenotype Acute Leukemia
: 2016-09-29
: - Drug: Cladribine Given IV
|
| Terminated |
: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
: - Acute Leukemias of Ambiguous Lineage
- Acute Undifferentiated Leu
: 2009-07-07
: - Drug: dexrazoxane hydrochloride
|
